English 
Spain 
Deutsch
GET A QUOTE
Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.
Description
Basic Info.
Mazdutide is a dual agonist of the GLP-1receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM).
The drug is developed by Eli Lilly and is currently in multiple Phase III studies.
In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity.
RTL Version
- RTL Version
- LTR Version
Send A Message
We'd love to hear from you if you have any questions!
Related Products
Lemon Bottle
Survodutide
Mazdutide
BPC 157 10mg+GHK-CU 50mg+TB500 10mg